INDmoney
Moonlake Immunotherapeutics Stock Performance
as on February 25, 2026 at 7:59 am IST
Day's Low
Day's High
$17.86$19.11
1.92%
Downside
4.94%
Upside
52 Week's Low
52 Week's High
$5.95$62.7567.33%
Downside
244.59%
Upside
Moonlake Immunotherapeutics share price movements today
- Previous Close
- $18.68
- Open
- $19.11
- Volume
- 1.3M
- Day's Low - High
- $17.86 - $19.11
- 52 Week Low - High
- $5.95 - $62.75
Moonlake Immunotherapeutics Historical Returns
- 1 Month Return
- + 14.75 %
- 3 Month Return
- + 33.73 %
- 1 Year Return
- -55.32 %
- 3 Year Return
- + 1.11 %
- 5 Year Return
- 0 %
Moonlake Immunotherapeutics Stock Fundamentals & Key Indicators
Check Moonlake Immunotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
-3.5449
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-227.0M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-54.33%
Moonlake Immunotherapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Moonlake Immunotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.3B | NA | NA | 0.00% | |
| BUY | $43.7B | 127.06% | 140.75 | 8.45% | |
| NA | $41.0B | NA | 712.77 | 1.38% | |
| BUY | $122.2B | 128.86% | 31.44 | 32.94% | |
| BUY | $83.2B | 70.39% | 18.97 | 31.41% |
Stock Returns calculator for Moonlake Immunotherapeutics Stock including INR - Dollar returns
The Moonlake Immunotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Moonlake Immunotherapeutics investment value today
Current value as on today
₹49,588
Returns
Returns from Moonlake Immunotherapeutics Stock
Dollar Returns*
₹4,879 (+4.88%)
Analyst Recommendation on Moonlake Immunotherapeutics Stock
Based on 22 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 22 analysts, 81.82% of analysts recommend a 'BUY' rating for Moonlake Immunotherapeutics. Average target price of $21.07
Moonlake Immunotherapeutics Share Price Target
Get share price movements and forecasts by analysts on Moonlake Immunotherapeutics.
What analysts predicted
13.57%UPSIDE
Target Price
$21.07
Current Price
$18.21
Analyzed by
22 Analysts
Target
$21.07
Moonlake Immunotherapeutics target price $21.07, a slight upside of 13.57% compared to current price of $18.21. According to 22 analysts rating.
Moonlake Immunotherapeutics Stock’s Investor Sentiment and Interest
Search interest for Moonlake Immunotherapeutics Stock has decreased by -71% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Moonlake Immunotherapeutics Quarterly Profit & Loss
All numbers in Millions USD
Moonlake Immunotherapeutics Annual Profit & Loss
All numbers in Millions USD
Moonlake Immunotherapeutics Quarterly Cash Flow
All numbers in Millions USD
Moonlake Immunotherapeutics Annual Cash Flow
All numbers in Millions USD
Moonlake Immunotherapeutics News & Key Events
Insights on Moonlake Immunotherapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, MLTX stock has moved up by 17.8%
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 71.9% return, outperforming this stock by 68.1%
- NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 42.7% return, outperforming this stock by 96.8%
About Moonlake Immunotherapeutics
| Organisation | Moonlake Immunotherapeutics |
| Headquarters | Dorfstrasse 29, Zug, Switzerland, 6300 |
| CEO | Dr. Jorge Santos da Silva Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Moonlake Immunotherapeutics
Name | Title |
|---|---|
Mr. Matthias Bodenstedt | Chief Financial Officer |
Mr. Oliver Daltrop Ph.D. | Chief Operations Officer |
Ms. Carla Bretes | Director of Investor Relations & External Communications |
Mr. Nicolas Mosimann Ph.D. | General Counsel |
Dr. Kristian Reich M.D., Ph.D. | Co-Founder & Chief Scientific Officer |
Joana Cortez | Senior Director Legal & Compliance |
Tino Anthamatten | Vice President of Marketing, Market Access & Pricing |
Luciana Marques | Director of HR, People & Culture |
Ms. Nuala Brennan | Chief Clinical Development Officer |
Dr. Jorge Santos da Silva Ph.D. | Co-Founder, CEO & Director |
FAQs
What is Moonlake Immunotherapeutics share price today?
Moonlake Immunotherapeutics share price today is $18.21 as on at the close of the market. Moonlake Immunotherapeutics share today touched a day high of $19.11 and a low of $17.86.
What is the 52 week high and 52 week low for Moonlake Immunotherapeutics share?
Moonlake Immunotherapeutics share touched a 52 week high of $62.75 on and a 52 week low of $5.95 on . Moonlake Immunotherapeutics stock price today i.e. is closed at $18.21,which is 70.98% down from its 52 week high and 206.05% up from its 52 week low.
What is Moonlake Immunotherapeutics's market capitalisation today?
Moonlake Immunotherapeutics market capitalisation is $0.00T as on .
How to invest in Moonlake Immunotherapeutics Stock (MLTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Moonlake Immunotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moonlake Immunotherapeutics Shares that will get you 0.0824 shares as per Moonlake Immunotherapeutics share price of $18.21 per share as on February 25, 2026 at 2:29 am IST.
What is the minimum amount required to buy Moonlake Immunotherapeutics Stock (MLTX) from India?
Indian investors can start investing in Moonlake Immunotherapeutics (MLTX) shares with as little as ₹90.899 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹908.99 in Moonlake Immunotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Moonlake Immunotherapeutics share’s latest price of $18.21 as on February 25, 2026 at 2:29 am IST, you will get 0.5491 shares of Moonlake Immunotherapeutics. Learn more about
fractional shares .